Dalmau discovered anti-NMDA autoimmune encephalitis in 2007 after recognizing a pattern in young patients whose psychiatric symptoms masked severe neurological inflammation. These rare diseases predominantly affect young people and women, with initial symptoms mimicking psychosis, leading many patients to be misdiagnosed in psychiatric units for years.
El Mundo
· May 20, 2026
· health
· 7 min read
High
Sourcing: Verified
Spanish neuroscientist Josep Dalmau identified 11 autoimmune encephalitis types masquerading as psychiatric disorders
Thousands of patients, particularly young people and women, were previously misdiagnosed with psychiatric disorders and confined to psychiatric units without proper treatment for their actual autoimmune neurological conditions.
◉
Health & Medicine
2774 related articles
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% match
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% match
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% match
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% match
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% match
Related Coverage
El País · Aug 21
Un hombre armado con una espada mata a una persona e hiere a varias en un instituto sueco
Un hombre de 18 años atacó con una espada a estudiantes en un instituto de Fagersta, Suecia, matando a una persona e hir…
UN News · Aug 21 Ébola en RD Congo: 2.500 muertos en cien días, con la mitad en las últimas tres semanasA cien días del brote de ébola en RD Congo, la epidemia ha causado más de 2500 muertes en territorio mayor que Francia, …
gob.pe · Aug 21 Lambayeque inicia campaña masiva de vacunación contra dengue para 30 mil estudiantesEl Gobierno Regional de Lambayeque lanzó una campaña de vacunación contra el dengue dirigida a 30,000 estudiantes de 10 …
Telemundo 52 · Aug 21 Retiran casi 40,000 frascos de gotas Clear Eyes por riesgo de contaminaciónPrestige Consumer Healthcare retira voluntariamente casi 40,000 frascos de gotas Clear Eyes Maximum Itchy Eye Relief por…
Bias & Framing
⚖
El Mundo presents Josep Dalmau's scientific achievements with celebratory framing and minimal critical perspective, emphasizing his exceptional contributions while downplaying individual credit.
Bias Direction
center-right
Confidence
MED
Hagiographic/celebratory framing that emphasizes individual scientific achievement and Spanish national pride. The article uses superlatives ('verdaderamente excepcionales', 'terrible enfermedad') and narrative storytelling to elevate Dalmau's status. Frames his work as transformative for patient care.
verdaderamente excepcionales ejemplos
terrible enfermedad
una guía
imborrables en su memoria
hazaña
destacados investigadores
Voices of patients affected by misdiagnosis prior to these discoveries
Perspectives from other researchers in the field on Dalmau's contributions
Challenges or limitations in implementing these diagnostic advances
Economic/healthcare system barriers to accessing these new diagnostic tools
Critical examination of diagnostic accuracy rates or remaining gaps
Geopolitical Impact
🌎
Spanish neuroscientist's discovery of autoimmune encephalitis types has medical significance but minimal geopolitical implications for international relations.
Escalation Risk
low
Confidence
HIGH
No significant power dynamics shifts. This is a scientific/medical advancement with potential healthcare benefits across nations.
Economic Lens
📈
Spanish neuroscientist's identification of 11 autoimmune encephalitis types could reduce misdiagnosis costs and improve treatment efficiency, benefiting healthcare systems and pharmaceutical development sectors.
Market Signal
bullish
Confidence
MED
Healthcare and medical services
Pharmaceutical and biotechnology
Medical diagnostics and testing
Mental health services
Medical research and development
Patients previously misdiagnosed with psychiatric disorders may receive correct treatment, reducing unnecessary psychiatric medications, improving health outcomes, and potentially lowering long-term healthcare costs for affected households.
Healthcare systems may need to update diagnostic protocols and training for neurologists and psychiatrists. Regulatory bodies may accelerate approval pathways for autoimmune encephalitis treatments. Insurance coverage policies may shift to reflect new diagnostic categories, potentially expanding reimbursement for specialized neuroimaging and immunological testing.